Literature DB >> 29145747

Two novel families with hemiplegic migraine caused by recurrent SCN1A mutation p.F1499L.

Victoria Schubert1, Eva Auffenberg1, Saskia Biskup2, Karin Jurkat-Rott3, Tobias Freilinger1.   

Abstract

Background Familial hemiplegic migraine type 3 is a monogenic subtype of migraine caused by missense mutations in the neuronal voltage-gated sodium channel gene SCN1A, with 10 different mutations reported so far. In two familial hemiplegic migraine type 3 families, partial cosegregation with a rare eye phenotype (elicited repetitive daily blindness) was previously reported. Methods Two novel familial hemiplegic migraine pedigrees were subjected to genetic analysis and detailed work-up of associated clinical features. Results In both pedigrees, we identified SCN1A mutation p.F1499L, which has been previously associated with familial hemiplegic migraine type 3 and elicited repetitive daily blindness. Both families displayed a pure familial hemiplegic migraine phenotype without evidence of an episodic eye phenotype. Conclusion Like a substantial proportion of other familial hemiplegic migraine type 3 mutations, p.F1499L affects the intracellular linker between domains III and IV of SCN1A, which seems to be a mutational hot-spot. Our new data establish p.F1499L as a recurrent familial hemiplegic migraine type 3 mutation. Elicited repetitive daily blindness seems to be a rare phenomenon in familial hemiplegic migraine type 3, even in carriers of the same mutation.

Entities:  

Keywords:  Migraine; SCN1A; elicited repetitive daily blindness; genetics; hemiplegic migraine; mutation

Mesh:

Substances:

Year:  2017        PMID: 29145747     DOI: 10.1177/0333102417742365

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

Review 1.  Sodium channelopathies of skeletal muscle and brain.

Authors:  Massimo Mantegazza; Sandrine Cestèle; William A Catterall
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

2.  Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene.

Authors:  R Barbieri; S Bertelli; M Pusch; P Gavazzo
Journal:  J Headache Pain       Date:  2019-11-15       Impact factor: 7.277

Review 3.  SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis.

Authors:  Jiangwei Ding; Xinxiao Li; Haiyan Tian; Lei Wang; Baorui Guo; Yangyang Wang; Wenchao Li; Feng Wang; Tao Sun
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

4.  Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model.

Authors:  Eva Auffenberg; Ulrike Bs Hedrich; Raffaella Barbieri; Daniela Miely; Bernhard Groschup; Thomas V Wuttke; Niklas Vogel; Philipp Lührs; Ilaria Zanardi; Sara Bertelli; Nadine Spielmann; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Michael Pusch; Martin Dichgans; Holger Lerche; Paola Gavazzo; Nikolaus Plesnila; Tobias Freilinger
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

5.  Familial Hemiplegic Migraine with an ATP1A4 Mutation: Clinical Spectrum and Carbamazepine Efficacy.

Authors:  Giangennaro Coppola; Grazia Maria Giovanna Pastorino; Luigi Vetri; Floriana D'Onofrio; Francesca Felicia Operto
Journal:  Brain Sci       Date:  2020-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.